002422 科伦药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额3,275,4255,337,0693,126,9582,847,1182,219,382
投资活动产生之现金流量净额(1,389,661)(3,370,325)(857,096)(1,529,790)(905,282)
筹资活动产生之现金流量净额(1,368,686)(2,058,766)(407,261)(1,270,756)(722,106)
汇率变动对现金及现金等价物的影响(10,344)5,1947,934(8,266)(28,207)
现金及现金等价物净增加/(减少)506,733(86,828)1,870,53538,306563,786
期初现金及现金等价物余额4,588,3244,675,1522,804,6172,761,7032,197,917
期末现金及现金等价物余额5,095,0574,588,3244,675,1522,800,0092,761,703